Visionary Physicist's Crusade Serves As Lesson In Futility

PRINCETON, NJ.—Drop a certain name in conversation with a fusion scientist or a Department of Energy official and you’re likely to observe an unusual reaction. Rolling eyes and sighs are common responses; mild cases of apoplexy are not unknown. Usually composed researchers become animated, others simply nod their heads knowingly. Rarely does the name pass without comment. The name is Bogdan Maglich, and the man who owns it claims he’s just a scientist with a relatively mo

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

PRINCETON, NJ.—Drop a certain name in conversation with a fusion scientist or a Department of Energy official and you’re likely to observe an unusual reaction. Rolling eyes and sighs are common responses; mild cases of apoplexy are not unknown. Usually composed researchers become animated, others simply nod their heads knowingly. Rarely does the name pass without comment.

The name is Bogdan Maglich, and the man who owns it claims he’s just a scientist with a relatively modest request: He’d like $2 million with which to build a fusion device smaller than a cubic centimeter, with an output of one kilowatt and practically no radioactivity. He calls it a “migma,” and he says that hundreds of migmas can be strung together to form enormous power plants.

Maglich is sure it will work. So sure, in fact, that he has formed a company, Advanced Physics Corp., to promote the idea. Its board ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Robert Crease

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide